X-Chem Overview
- Year Founded
-
2009

- Status
-
Private
- Employees
-
182

- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
6
- Investments
-
3
X-Chem General Information
Description
Provider of biotechnological services in Waltham, Massachusetts. The company's biotechnological services include drug discovery generated by iterative combinatorial synthesis of small molecules tethered to DNA tags that record the synthetic history of the small molecule.
Contact Information
Website
www.x-chemrx.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 100 Beaver Street
- Suite 101
- Waltham, MA 02453
- United States
+1 (781) 000-0000
X-Chem Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
X-Chem Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Provider of biotechnological services in Waltham, Massachusetts. The company's biotechnological services include drug di
Drug Discovery
Waltham, MA
182
As of 2023
0000
000000000 00
X-Chem Competitors (17)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Editas Medicine | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000000 | 00000 |
00000000 | Venture Capital-Backed | Saffron Walden, United Kingdom | 000 | 000 | 00000000000 | 000 |
0000000 000000000 | Formerly VC-backed | Cambridge, United Kingdom | 000 | 00000 | 0000000000 | |
0000000000 0000000 | Venture Capital-Backed | San Diego, CA | 00 | 000 | 0000000000 0 | 000 |
000000 0000000 | Corporation | Lund, Sweden | 0 | 000.00 | 000000000 | 000.00 |
X-Chem Patents
X-Chem Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220275362-A1 | Methods for tagging and encoding of pre-existing compound libraries | Inactive | 25-Jul-2019 | 00000000000 | |
CA-3144759-A1 | Methods for tagging and encoding of pre-existing compound libraries | Pending | 25-Jul-2019 | 00000000000 | |
EP-4004202-A1 | Methods for tagging and encoding of pre-existing compound libraries | Inactive | 25-Jul-2019 | 00000000000 | |
CA-3144652-A1 | Recombinant transfer vectors for protein expression in insect and mammalian cells | Pending | 27-Jun-2019 | 000000000 | |
EP-3990640-A1 | Recombinant transfer vectors for protein expression in insect and mammalian cells | Inactive | 27-Jun-2019 | C12N15/85 |
X-Chem Executive Team (20)
X-Chem Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
0000 000000 | GHO Capital | Board Member | 000 0000 |
0000000 00000000 | GHO Capital | Board Member | 000 0000 |
X-Chem Signals
X-Chem Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
X-Chem Investments (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000000 00 | 28-Oct-2021 | 0000000000 | Discovery Tools (Healthcare) | 0000000 0 | |
00000000 | 25-Oct-2021 | 0000000000 | BPO/Outsource Services | 0000000 0 | |
IntelliSyn Pharma | 26-Jan-2021 | Buyout/LBO | BPO/Outsource Services | 0000000 0 |
X-Chem Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
000000000 00 | Discovery Tools (Healthcare) | London, United Kingdom | 0000 |